STAT
MARCH 13, 2025
Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. In a new study in the BMJ , researchers analyzed the Food and Drug Administration database where manufactures report adverse events and found that a huge number of reports come in late.
The Pharmacist
MARCH 13, 2025
NHS England (NHSE) will be scrapped and brought back into the Department of Health and Social Care (DHSC) 'to put an end to the duplication resulting from two organisations doing the same job', the government has said today. Prime Minister Sir Kier Starmer set out major reforms today, which will include the dissolution of NHSE […] The post NHS England to be scrapped with funding 'reinvested into frontline services' appeared first on The Pharmacist.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
MARCH 13, 2025
In May 2024, the Massachusetts Department of Public Health released a troubling report on a cluster of HIV infections, with more than 200 new cases since 2018 attributable to injection drug use in the Boston region. These findings have national implications: Similar HIV outbreaks have been described nationwide during the overdose crisis, including in West Virginia , Indiana , and Ohio.
The Pharmacist
MARCH 13, 2025
Money to develop IT systems to support the roll-out of Pharmacy First was 'not well spent', pharmacist and MP Sadik Al-Hassan has suggested. The Labour MP for North Somerset was speaking at a roundtable focusing on community pharmacy technology in parliament yesterday when he was asked by The Pharmacist for his views on the IT […] The post Pharmacy First IT funding 'not well spent', says pharmacist MP appeared first on The Pharmacist.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
STAT
MARCH 13, 2025
This was supposed to be the year of biotech’s comeback. At least that was the hope of many in the sector who started 2025 pointing to scientific advances and falling interest rates. Some foresaw a pickup in buyouts and initial public offerings, rewarding investors in the highly risky and cyclical business of bringing drugs to market. But three months into the new year, the mood has soured and the outlook has clouded as a cyclone of threats and unknowns gathers speed.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
STAT
MARCH 13, 2025
A new biotech is raising money to develop a drug believed to be capable of starving cancer cells, based on research out of lauded cancer researcher Bert Vogelstein’s lab. The Boston-based company, Cage Pharma, has already received funding from Catalio Capital Management and hopes to raise up to $35 million in a Series A round, according to a person with knowledge of the company’s plans.
The Pharmacist
MARCH 13, 2025
A daily pill has been approved by NICE for treating some women with endometriosis after initially being rejected. It is estimated around 1,000 patients a year will be able to access the treatment called relugolixestradiolnorethisterone (also known as relugolix combination therapy or Ryeqo). The turnaround from NICE came after the company provided new evidence on […] The post NICE approves daily pill for endometriosis where other treatments have failed appeared first on The Pharmacist.
STAT
MARCH 13, 2025
This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. I can’t stop saying “loraz-a-payum” thanks to Parker Posey in “The White Lotus.” Housekeeping note: I’ll be in New York City next week for STAT’s Breakthrough Summit East event on March 20.
Express Pharma
MARCH 13, 2025
H.E.L Group, a global developer and manufacturer of laboratory tools for process optimisation, safety, and scale-up, has entered into a research agreement with the Institute of Chemical Technology (ICT) in Mumbai. The three-year strategic alliance aims to advance process safety in the chemical synthesis industry. The collaboration will focus on H.E.Ls Process Safety Hub alongside ICT Mumbais academic and research expertise in chemical sciences, engineering, and related fields.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
MARCH 13, 2025
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Are you tired of reading about potato chips yet? Well, after a lot of hearty debate about flavors, yesterday at STAT we learned that chips were originally sold without any flavor at all. Until the mid-50s, they just came with one little packet of salt that you could pour over them.
Express Pharma
MARCH 13, 2025
A recent study published in Springer Medizin has identified insulinoma-associated protein 2 autoantibody (IA-2A) positivity as a significant biomarker for disease progression in individuals at risk of type 1 diabetes (T1D). The findings are particularly relevant as the T1D market undergoes a transformation driven by advancements in predictive diagnostics and disease-modifying therapies.
STAT
MARCH 13, 2025
Rise and shine, everyone, another busy day is on the way. We can tell by the parade of motor vehicles passing by the Pharmalot campus and the continuous rumble of commuter trains off in the distance. As for us, we are engaged in the usual ritual of brewing cups of stimulation. Our choice today is strawberry creme, another household favorite. As always, you are invited to join us.
PharmaVoice
MARCH 13, 2025
The pharma giant announced a new partnership with BridGene Biosciences that will use its IMTAC platform for drug discovery.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
The Pharmacist
MARCH 13, 2025
Community pharmacy leaders have expressed hope that the government's decision to abolish NHS England (NHSE) will mean more funding can be redirected to community pharmacy. Meanwhile, the sector's negotiator has pledged to work with 'whatever new structures and teams' are in place, while continuing to be 'fully focused' on current funding negotiations.
Pharma Marketing Network
MARCH 13, 2025
Table of Contents The Impact of a Pharma Ad Ban on TV Digital Marketing as a Primary Alternative Leveraging Data-Driven Advertising Strategies Strengthening Direct-to-Consumer (DTC) Engagement The Impact of a Pharma Ad Ban on TV The potential for a pharma ad ban on TV has sparked intense discussions among marketing executives. If regulations change, pharmaceutical brands must rethink their advertising strategies to maintain visibility and patient engagement.
European Pharmaceutical Review
MARCH 13, 2025
NICE has recommended the first daily oral pill on the NHS to treat endometriosis. The new final draft guidance from NICE follows its earlier negative recommendation of relugolix estradiolnorethisterone (Ryeqo) relugolix combination therapy for this indication. The treatment offers key benefits including its administration by patients at home. “Instead of travelling to clinics for injections, there is now a daily tablet that can be taken at home,” stated Helen Knight , Director of Med
Pharmaceutical Business Review
MARCH 13, 2025
This initiative is stated to be a part of the company’s Phase I contract development and manufacturing organisation (CDMO) growth strategy. In response to the growing need for dependable production in the US, the expanded facility will help the company to enhance capacity for suspension, liquid, semi-solid, as well as suppository drug products.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Patent Watch
MARCH 13, 2025
Navigating the Complex World of Biosimilar Supply Chains As the demand for biosimilars continues to grow, so do the challenges associated with their supply chains. From manufacturing and quality control to distribution and regulatory compliance, the stakes are high for pharmaceutical companies looking to bring these life-changing treatments to market.
Pharma Marketing Network
MARCH 13, 2025
Table of Contents Understanding the Role of AI in Pharma Marketing Key Benefits of AI Integration in Pharma Marketing AI-Powered Strategies for Pharma Marketers Overcoming Challenges in AI Adoption Understanding the Role of AI in Pharma Marketing The pharmaceutical industry is undergoing a digital transformation, and AI in pharma marketing is at the forefront of this evolution.
BioPharma Dive
MARCH 13, 2025
The joint venture with generative AI firm Hologen hands MeiraGTx $200 million up front as well as other financial perks — a “transformative” deal, according to the company’s CEO.
Pharma and Life Sciences Blog
MARCH 13, 2025
Transforming Global Procurement With Autonomous AI Agents priyanka.katke Thu, 03/13/2025 - 20:54 Were approaching a world where your procurement operations run seamlessly, costs are cut, and efficiency is maximized all while you focus on strategic growth, thanks to autonomous AI agents. Our new bulletin unveils how CPOs and visionary leaders are leveraging AI to revolutionize procurement on a global scale.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
BioPharma Dive
MARCH 13, 2025
The merger will give the combined entity the financial flexibility to pursue drug licensing deals and broaden its therapeutic focus, executives said on a conference call.
Pharma Times
MARCH 13, 2025
Immunoglobulin therapy improves mobility in phase 2/3 study
pharmaphorum
MARCH 13, 2025
Kelun-Biotech wins first global regulatory approval, in China, for a TROP2-directed antibody-drug conjugate (ADC) in lung cancer
Pharma Times
MARCH 13, 2025
EC extends brexpiprazole indication to include adolescents
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Pharmacy Times
MARCH 13, 2025
Panelists discuss how health care professionals develop personalized menopause management strategies by comprehensively assessing individual medical history, symptom profiles, lifestyle factors, and potential risks. Through transparent, collaborative counseling, they guide patients in making informed decisions about pharmacologic therapies, prioritizing personalized care and holistic well-being.
Pharmaceutical Technology
MARCH 13, 2025
Emergent has entered a strategic financial investment agreement with Swiss Rockets to support the latters biotech portfolio.
Pharmaceutical Commerce
MARCH 13, 2025
The CRDMOs acquisition of the Baltimore plant is expected to boost its biologics presence.
Expert insights. Personalized for you.
263 
Let's personalize your content